Skip to content

Atezolizumab

Published: August 9, 2026Updated: August 9, 2026

Tecentriq (atezolizumab) is a PD-L1 inhibitor immunotherapy drug used to treat multiple types of cancer. It works by blocking the PD-L1 protein, which helps remove the brakes on the immune system, allowing T-cells to better recognize and attack cancer cells. This medication is prescribed for certain lung, breast, bladder, liver cancers, and melanoma.

Quick summary

Tecentriq is an immunotherapy drug that helps the immune system fight cancer by blocking PD-L1 proteins.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 9, 2026Editorial policy

Key facts at a glance

RxNorm
1792781
Generic
Tecentriq
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Tecentriq is used to treat non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), triple-negative breast cancer, urothelial carcinoma of the bladder, hepatocellular carcinoma (liver cancer), and melanoma. It may be used alone or in combination with other cancer treatments.

Tecentriq is a monoclonal antibody that binds to the PD-L1 protein on tumor cells and immune cells. By blocking PD-L1, it prevents the protein from interacting with PD-1 and B7.1 receptors, effectively releasing the brakes on the immune system and allowing T-cells to identify and destroy cancer cells more effectively.

Tecentriq is administered as an intravenous infusion by a healthcare professional. Common side effects include fatigue, decreased appetite, and infusion reactions. It can cause serious immune-related side effects affecting the lungs, liver, colon, and other organs. Patients should be monitored closely during treatment and report any new or worsening symptoms immediately.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 9, 2026. · Read our editorial policy